![Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/09/ced-pexels-13091435.jpg?resize=150%2C150&ssl=1 "Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] 2")
What the Latest Dronabinol PTSD Nightmares Clinical Trial Reveals
A recent dronabinol PTSD nightmares clinical trial involving 171 adults demonstrated that this FDA-approved synthetic THC medication significantly reduces nightmare frequency and intensity. The trial highlights dronabinol's targeted effect on…
2026 Review: Cannabinoids in Managing MS Spasticity
This 2026 systematic review evaluates cannabinoids for MS spasticity, finding modest improvements with THC:CBD extracts. Despite low evidence certainty, cannabinoids may aid some patients with MS spasticity as adjunctive therapy. Careful clinical…
Clinical Efficacy of Dronabinol for PTSD Nightmares: Insights from a 171-Person Trial
A 171-person randomized controlled trial demonstrates dronabinol PTSD nightmares clinical efficacy, significantly reducing nightmare frequency and intensity. This FDA-approved synthetic THC medication offers targeted relief for PTSD-related nightmares…
The DEA Rescheduling Hearing Is Over. A New Commentary Argues States Should Lead the Next Phase of Cannabis Research
The DEA rescheduling hearing has concluded, but the clinical benefits depend on state cannabis research policy. States with mature medical programs must build infrastructure to convert lowered federal barriers into usable clinical evidence. This…
Are We Over-Diagnosing Cannabis Use Disorder in Prescribed Medical Cannabis Patients?
prescription cannabis use disorder: A new Addiction journal study of 2,054 Australians prescribed medical cannabis found that removing tolerance and withdrawal from Cannabis Use Disorder criteria cut apparent disorder rates among as-prescribed patients…
THC:CBD Oil for Spinal Cord Injury Spasticity- What a Pilot Trial Found
THC CBD oil for spinal cord injury spasticity: A placebo-controlled crossover pilot tested balanced THC:CBD oil in 16 people with chronic spinal cord injury. The objective primary spasticity measure did not significantly improve, while one patient-rated…
CBD and Nonseizure Outcomes in Epilepsy: What a New Systematic Review Shows
This systematic review examines CBD nonseizure outcomes epilepsy, analyzing 32 studies with 1,343 patients. It reports consistent improvements in cognition, behavior, and other nonseizure domains, though evidence is mostly observational and requires…
Dronabinol Cuts PTSD Nightmares in a New Randomized Trial
Dronabinol PTSD nightmares: a randomized, placebo-controlled trial in more than 170 adults found nightly oral THC significantly reduced PTSD-related nightmares over 10 weeks. More than a third of treated patients became nightmare-free. Overall PTSD…
Cannabis Use, Cannabis Use Disorder Are Not The Same
Cannabis use and cannabis use disorder showed partly different genetic relationships with selected brain-imaging traits in a large 2026 analysis. The findings support treating use and disorder as related but noninterchangeable research phenotypes. They…
Cannabinoids for MS Spasticity: What 27 Randomized Trials Show
cannabinoids for MS spasticity: A systematic review of 27 randomized trials found modest patient-reported improvement in multiple-sclerosis spasticity, especially with THC:CBD extracts. Objective benefits were limited and the certainty of evidence was…